vaginal ring eluting etonogestrel and ethinyl estradiol

Uses• abnormal uterine bleeding
• dysmenorrhea
• menorrhagia
• polycystic ovarian syndrome
Contraindications,
drug interactions
or cautions
Contraindications
• breast cancer or other estrogen- or progestin-dependent neoplasms
• women at high risk of arterial or venous thrombotic diseases
• migraine with aura
• uncontrolled hypertension
• women >35 years of age who smoke
• inherited/acquired coagulopathies
Drug Interactions
• anticonvulsants
• antibiotics
• benzodiazepines
• barbiturates
• antihistamines
• analgesics
Adverse Effects (common and severe)• headache
• vaginitis
• leukorrhea
• acne
• breast tenderness
• nausea
Instructions and dose
(initial; typical)
one ring, inserted vaginally and left in place for 3 consecutive weeks, then removed for 1 week. new ring inserted 7 days after the last was removed.
Monitoringblood pressure
Source of Suggestion
WHO Model List of Essential Medicines
(Added on August, 2015)